HopeStage
Back to all studies
RecruitingNCT06326684

Suvorexant or placebo in a study of alcohol-related motivation and behavior

About this titleRead the official source — NCT06326684
Medication studyAges 21–55United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 55 years.

Listed locations
LexingtonSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 7, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
William Stoops
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT06326684
Official title
Show the full official title

Influence of Orexin Antagonism on Motivation for Alcohol

Recruitment & locations

Currently recruiting

Lexington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is William Stoops.

Does this study involve medication?

Yes. The study involves medication, including Alcohol, Placebo and Suvorexant.

Who can participate?

Listed age limits: 21 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies